438 related articles for article (PubMed ID: 27199356)
21. Novel Kappa Opioid Receptor Agonist as Improved PET Radiotracer: Development and in Vivo Evaluation.
Li S; Zheng MQ; Naganawa M; Gao H; Pracitto R; Shirali A; Lin SF; Teng JK; Ropchan J; Huang Y
Mol Pharm; 2019 Apr; 16(4):1523-1531. PubMed ID: 30726092
[TBL] [Abstract][Full Text] [Related]
22. Further evaluation of [11C]MP-10 as a radiotracer for phosphodiesterase 10A: PET imaging study in rhesus monkeys and brain tissue metabolite analysis.
Lin SF; Labaree D; Chen MK; Holden D; Gallezot JD; Kapinos M; Teng JK; Najafzadeh S; Plisson C; Rabiner EA; Gunn RN; Carson RE; Huang Y
Synapse; 2015 Feb; 69(2):86-95. PubMed ID: 25450608
[TBL] [Abstract][Full Text] [Related]
23. Kinetic Modelling and Test-Retest Reproducibility for the Dopamine D
Bertoglio D; Verhaeghe J; Miranda A; Wyffels L; Stroobants S; Dominguez C; Munoz-Sanjuan I; Skinbjerg M; Liu L; Staelens S
Mol Imaging Biol; 2021 Apr; 23(2):208-219. PubMed ID: 33179158
[TBL] [Abstract][Full Text] [Related]
24. A metabolically stable PET tracer for imaging synaptic vesicle protein 2A: synthesis and preclinical characterization of [
Zheng C; Holden D; Zheng MQ; Pracitto R; Wilcox KC; Lindemann M; Felchner Z; Zhang L; Tong J; Fowles K; Finnema SJ; Nabulsi N; Carson RE; Huang Y; Cai Z
Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1482-1496. PubMed ID: 34761284
[TBL] [Abstract][Full Text] [Related]
25. Preclinical Evaluation of a P2X7 Receptor-Selective Radiotracer: PET Studies in a Rat Model with Local Overexpression of the Human P2X7 Receptor and in Nonhuman Primates.
Ory D; Celen S; Gijsbers R; Van Den Haute C; Postnov A; Koole M; Vandeputte C; Andrés JI; Alcazar J; De Angelis M; Langlois X; Bhattacharya A; Schmidt M; Letavic MA; Vanduffel W; Van Laere K; Verbruggen A; Debyser Z; Bormans G
J Nucl Med; 2016 Sep; 57(9):1436-41. PubMed ID: 27199364
[TBL] [Abstract][Full Text] [Related]
26. The Search for a Subtype-Selective PET Imaging Agent for the GABA
Lin SF; Bois F; Holden D; Nabulsi N; Pracitto R; Gao H; Kapinos M; Teng JK; Shirali A; Ropchan J; Carson RE; Elmore CS; Vasdev N; Huang Y
Mol Imaging; 2017; 16():1536012117731258. PubMed ID: 28929924
[TBL] [Abstract][Full Text] [Related]
27. Preclinical Evaluation and Quantification of 18F-FPEB as a Radioligand for PET Imaging of the Metabotropic Glutamate Receptor 5.
de Laat B; Leurquin-Sterk G; Celen S; Bormans G; Koole M; Van Laere K; Casteels C
J Nucl Med; 2015 Dec; 56(12):1954-9. PubMed ID: 26405172
[TBL] [Abstract][Full Text] [Related]
28. First-in-human evaluation of 18F-mefway, a PET radioligand specific to serotonin-1A receptors.
Hillmer AT; Wooten DW; Bajwa AK; Higgins AT; Lao PJ; Betthauser TJ; Barnhart TE; Rowley HA; Stone CK; Johnson SC; Mukherjee J; Christian BT
J Nucl Med; 2014 Dec; 55(12):1973-9. PubMed ID: 25453045
[TBL] [Abstract][Full Text] [Related]
29. First-in-Human Evaluation of
Naganawa M; Li S; Nabulsi N; Henry S; Zheng MQ; Pracitto R; Cai Z; Gao H; Kapinos M; Labaree D; Matuskey D; Huang Y; Carson RE
J Nucl Med; 2021 Apr; 62(4):561-567. PubMed ID: 32859701
[TBL] [Abstract][Full Text] [Related]
30. First-in-human PET quantification study of cerebral α4β2* nicotinic acetylcholine receptors using the novel specific radioligand (-)-[(18)F]Flubatine.
Sabri O; Becker GA; Meyer PM; Hesse S; Wilke S; Graef S; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Habermann B; Neuhaus P; Fischer S; Tiepolt S; Deuther-Conrad W; Barthel H; Schönknecht P; Brust P
Neuroimage; 2015 Sep; 118():199-208. PubMed ID: 26037057
[TBL] [Abstract][Full Text] [Related]
31. Quantitative Analysis of
Takano A; Chen L; Nag S; Brodney MA; Arakawa R; Chang C; Amini N; Doran SD; Dutra JK; McCarthy TJ; Nolan CE; O'Neill BT; Villalobos A; Zhang L; Halldin C
J Nucl Med; 2019 Jul; 60(7):992-997. PubMed ID: 30530832
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, 18F-Radiolabelling and Biological Characterization of Novel Fluoroalkylated Triazine Derivatives for in Vivo Imaging of Phosphodiesterase 2A in Brain via Positron Emission Tomography.
Schröder S; Wenzel B; Deuther-Conrad W; Teodoro R; Egerland U; Kranz M; Scheunemann M; Höfgen N; Steinbach J; Brust P
Molecules; 2015 May; 20(6):9591-615. PubMed ID: 26016549
[TBL] [Abstract][Full Text] [Related]
33. Imaging of the striatal and extrastriatal dopamine transporter with (18)F-LBT-999: quantification, biodistribution, and radiation dosimetry in nonhuman primates.
Varrone A; Stepanov V; Nakao R; Tóth M; Gulyás B; Emond P; Deloye JB; Vercouillie J; Stabin MG; Jonsson C; Guilloteau D; Halldin C
J Nucl Med; 2011 Aug; 52(8):1313-21. PubMed ID: 21764797
[TBL] [Abstract][Full Text] [Related]
34. In vivo assessment and dosimetry of 2 novel PDE10A PET radiotracers in humans: 18F-MNI-659 and 18F-MNI-654.
Barret O; Thomae D; Tavares A; Alagille D; Papin C; Waterhouse R; McCarthy T; Jennings D; Marek K; Russell D; Seibyl J; Tamagnan G
J Nucl Med; 2014 Aug; 55(8):1297-304. PubMed ID: 24898025
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and evaluation of nicotine alpha4beta2 receptor radioligand, 5-(3'-18F-fluoropropyl)-3-(2-(S)-pyrrolidinylmethoxy)pyridine, in rodents and PET in nonhuman primate.
Chattopadhyay S; Xue B; Collins D; Pichika R; Bagnera R; Leslie FM; Christian BT; Shi B; Narayanan TK; Potkin SG; Mukherjee J
J Nucl Med; 2005 Jan; 46(1):130-40. PubMed ID: 15632043
[TBL] [Abstract][Full Text] [Related]
36. Investigation of an
Schröder S; Wenzel B; Deuther-Conrad W; Teodoro R; Kranz M; Scheunemann M; Egerland U; Höfgen N; Briel D; Steinbach J; Brust P
Molecules; 2018 Mar; 23(3):. PubMed ID: 29498659
[TBL] [Abstract][Full Text] [Related]
37. Assessment of test-retest reproducibility of [
Li S; Naganawa M; Pracitto R; Najafzadeh S; Holden D; Henry S; Matuskey D; Emery PR; Cai Z; Ropchan J; Nabulsi N; Carson RE; Huang Y
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1327-1338. PubMed ID: 33416954
[TBL] [Abstract][Full Text] [Related]
38. Preclinical evaluation of a promising C-11 labeled PET tracer for imaging phosphodiesterase 10A in the brain of living subject.
Liu H; Jin H; Yue X; Zhang X; Yang H; Li J; Flores H; Su Y; Perlmutter JS; Tu Z
Neuroimage; 2015 Nov; 121():253-62. PubMed ID: 26216275
[TBL] [Abstract][Full Text] [Related]
39. Test-retest reliability of the novel 5-HT1B receptor PET radioligand [11C]P943.
Saricicek A; Chen J; Planeta B; Ruf B; Subramanyam K; Maloney K; Matuskey D; Labaree D; Deserno L; Neumeister A; Krystal JH; Gallezot JD; Huang Y; Carson RE; Bhagwagar Z
Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):468-77. PubMed ID: 25427881
[TBL] [Abstract][Full Text] [Related]
40. Development of two fluorine-18 labeled PET radioligands targeting PDE10A and in vivo PET evaluation in nonhuman primates.
Stepanov V; Takano A; Nakao R; Amini N; Miura S; Hasui T; Kimura H; Taniguchi T; Halldin C
Nucl Med Biol; 2018 Feb; 57():12-19. PubMed ID: 29223715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
